The aim of this review article is to summarize current concepts in unilateral recurr ent laryng eal nerve paralysis (URLNP). Important aspects of laryn geal phylogenesis, physiology, and anatom y are reviewed. Recent advanees in the neurophysiolo gy of URLNP are discussed. Revised and updated prin ciples of diagnosis and treatment are pro vided. Glottic config uration and prognosis VGJY accordin g to the type ofneural lesion (neurapraxia, axonotm esis, O I' neurotmesis). Therapeutic indications depend on glottic configuration and prognosis. Treatment options include medialization thyrop lasty, vocal fold augmentation by injection, arytenoid addu ction, and laryngeal reinn ervation. Each treatm ent option is summarized, and the results reported in the medical literature are reviewed.
Introduction
Unilateral reeurrent laryngeal nerve paralysis (URLNP) result s in glottie ineompetenee. The glottie configuration varies aeeording to neurophysiologie laws that are as yet incompletely elueidated. The severity of symptoms such as weak and bre athy voice, phonatory effort, ineffieient eough, and aspiration varies as weil. Aspiration in URLNP Laborator y of voice . biornaterials and ce rvicofac ial oncology , CNRS-UPRESA 70 ean be life-threatening in patients with compromised pulmonary funct ion . Dysphonia diminishes oral communication and qua lity of life. Therapeutie options in URLNP began to flouri sh toward the end of the 20 th eentury. There are now four main approaehes to vocal fold medialization : intraeordal injeetion techniques , external medialization thyroplasty , aryteno id adduetion, and laryngeal reinnervation. Eaeh technique has speeifie indieations and advantages. Knowledge of laryngeal ana tomy , phy siology, and neurophysiology is necessary to determine the optimum procedure for a given etiology and laryngeal eonfiguration.
The aim of this review article is to relate eurrent coneepts in laryngeal physiology and neurophysiology and to summarize current therapeutie options for URLNP.
Phylogenesis
Several notion s in laryngeal phylogenesis are helpfu l in understanding laryngeal physiology and pathology in humans.':' From a phylogenetic point ofview, the larynx is above all a sphineter situated at the inlet of the lower airways, proteeting them from water and food penetration . The most primitive larynx, in eertai n fish, is simp ly a eircular smooth muscle , contraeted at rest, keeping water from entering the primitive lung saes. These fish fill the primitive lung saes with air using a swallowing motio n accompanied by the relax ation of the eircular sphineter.
Adaptations allow amph ibian s to move from a purely aquatic atmo sphere to live on land . The branc hial apparatus disappears. The first species to have a structured larynx are the polypterus (or lungfish). Their larynx has a rigid fibrous strueture and a dilator muse le in addition to a constrictor muscle. This laryngeal structure allows for an open laryngeal eonfiguration on land and a closed laryn x under water. More evolved amphibians have more elaborate cartilaginous structures and more dilator muscles .
Reptil es are the first land-dwelling vertebrates who only breathe air. The ir larynx sits high on the hyoid bone , just behind the tong ue base. The intrinsie muscles are formed of a pair of dil ator muscles and a pair of eonstrietor • Patients also reported significant improvement in ability to chew and swallow tood'
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Birds have a reptiIian larynx but, contrary to reptiles, they can lower their larynx and breathe through the mouth. The larynx is by no mean s responsible for song in birds , as the arytenoid cartil ages are im mobil e and there are no voca l folds. Th e larynx is stiIl only a sphincter. Song is produced by the syr inx, a unique organ situated at the carin a and around the main bronchi. A cartil aginous structure called the tympanum, or drum, form s the base for insertion of tympaniform membranes capable of vibrating. A complex group of muscles, innervated by the hypoglossus ner ve, modulates the tension of the membranes and the dimension s of the drum and thus the reson ant frequency of the syrinx-in other word s, the melody of the song . Some bird s even have physiologic diplophonia, aresult of the two halves of the syrinx vibrating asynchronously.
In mar supi als, the thyroid cartilage det ache s from the hyoid bon e with a slight descent of the larynx as compared to reptiles, in which these cartil ages are welded together. The cricoid and thyroid cartil age s and the cric oid and arytenoid cartilages remain solidly fixed together and immobile. Marsupials produce very little sound.
In mammals, the larynx take s on very different positions and configurations. In all species, the hyoid bone, the thyroid cartilage, the cricoid carti lage, and the arytenoids are independent and mobile. In most mammais, the larynx is in a high position just beiow the nasopharynx. Thi s assures clo se contact for nasal breathing necessary for keen al fact ion . In chimpanzees, the cricoid ca rtilage is at the le vel of the fourth cervical vertebra, compared with the fifth 0 1'sixth in adult humans. Th e mo st extreme exa mple of a high larynx are the ceta cean s, whose larynx is in the nasoph arynx ju st beiow the cephaIic blowhole. In oth er species, the epi glottis , with gu statory papillae, touches the velum, creating a direet connection between the nasoph arynx and the larynx with littl e 01' no communication with the oropha rynx. Thi s allo ws some species to ea t while keeping their olfaction free for detecting pred ators. Thi s high-situated laryn geal configuration is also found in hum an newb orn s, who can breathe through the nose and swallow simuItaneously.
Fortree-cIimbing species, laryngeal occlu sion is essential for stabilizing the thorax , pro vidin g a stable pivot point for the muscles of the upper limbs. And for all mammals, laryngeal occlusion permit s the increase in intrath oraci c pressu re ne cessary for co ug hing and sneezing.
In humans, the larynx has four basic functi ons : air Volume 79, Number 11 breathing, occlu sion for protection of the inferior airways during swallowing, occlusion for the increase in intrathoracic .(cough) or intra-abdominal (defecation) pre ssure and stabiliza tion of the superior limbs , and finall y phonation. The lower laryngeal position, the short velum, and the post eriorly situated tongue base are con sidered as the most important phylogenetic modifications allowing oral speech production in humans, I as opposed to our simian 01' Neand erthal ancestors . Th ese modifications of the vocal tract accompany a flexion of the cranial base, which is flatter in primates. Th e modifications seem to have occurred to the detriment of the protective, sphincteric function of the larynx, as compared with other mamrnaIs. In summary, the larynx initially developed as a sphincter protecting the lower airways. A cartilaginous structure permitted a dilated laryngeal configuration in air-breathing species . Anatomic differences among species developed to improve olfaction orto facilitate large movements of the upper limbs. Only in humans has the larynx evol ved as primarily a speaking organ, due, it seern s, to the lower laryngeal position, the short velum, and the posterior tongue base. It seems that the phon atory function of the larynx has developed to the detriment of its protective and olfactory func tion s.
Laryngeal physiology
The larynx is involved in four basic physiologic functions : swallowing, breathing, cough, and phon ation. It is also invol ved in certain reflexes and in mo vement s nece ssitating glottic occlu sion.
Swallowing. The preceding section has shown that the first role of the larynx is protection of the lower airways. The low laryngeal position in man, as opposed to other species, appears to be a factor in the high incidenee of aspiration in hum ans. Swallowin g can be described in four stages. The first two-oral prep aratory and oral-are voluntary. The food bolu s form ed during the first phase is propelled toward the tongue base in the second phase.Y Th e third phasepharyngeal-starts when the bolus arrives at the tongue base. This phase is, in fact , a complex reflex combining cranial nerves IX, X, and XII, the reticular formation of the medulla, the respir atory centers of the brainstem, and probably the cerebral cortex itself. It is evoked by the sensory stimulation of phar yngeal and supraglottic structures.
Apnea marks the beginning of the pharyngeal ph ase. The velum rises, occluding the nasopharynx. The tongue base mo ves backward as the larynx is raised anteriorly. The larynx eloses from inferiorto superior with adduction of the true voc al fold s, the false vocal fold s, and then the arytenoids and aryepiglottic fold s. The anterior laryngeal motion moves the glotti s out of the direet line between the oropharynx and the hypopharynx and leads to a relative 863 HARTL , BRASNU opening of the hypopharynx and the upper esophagus. Adduction of the aryepiglottic folds and posterior displacement of the epiglottis, which is pushed by the tongue base, creates a furrow on each side , directing the food bolus toward the piriform sinuses.
The last event in the pharyngeal phase is the relaxation of the upper esophageal sphincter. The entire pharyngeal phase lasts I second. The esophageal phase follows with peristaltic motion of the esophageal smooth muscle. Aspiration due to recurrent laryngeal nerve paralysis occurs generally during the pharyngeal phase due to insufficient laryngeal occlusion, but abnormalities in upper esophageal sphincter tone and relaxation have been documented in URLNP.6
Breathing. The glottis is divided functionally into two distinct but interdependent parts. The posterior glottis (or respiratory glottis or cartilaginous glottis) is located between the bodies and the vocal proeesses of the two arytenoids. It represents approximately 45% of the anterior-posterior length of the glottis. ' The anterior glottis (or phonatory glottis or membranous glottis) is formed by the musculomembranous part of the vocal folds, which vibrate during phonation. Both the anterior and posterior parts of the glottis are involved in breathing and in phonation, however. During phonation, the posterior glottis regulates laryngeal aerodynamics, which in turn affect the vibratory qualities of the anterior glottis.' Glottic elosure is obtained by a complex movement of the cricoarytenoid joint. The joint is comprised of two elliptical surfaces, with their major axes directed perpendicularly. The cricoidjoint surface is convex superiorly, with its major axis directed in an anterolateral direction. The smaller arytenoid surface is concave inferiorly, with its major axis directed in an anteromedial direction. This configuration allows for two types of motion: medial rocking of the body of the arytenoid along the short axis of the cricoid surface and forward sliding of the body of the arytenoid along the long axis of the cricoid surface. The combined effect of these two movements produces a medial and caudal displacement of the vocal process during adduction and a lateral and cranial displacement of the vocal process during abduction. "Rotation" of the arytenoid does not and cannot occur physiologically due to the configuration of the cricoarytenoid joint and its ligaments.8-10 Other types of complex motion are possible, such as the posterior approximation of the arytenoid bodies. It appears that the posterior glottis can be modified almost completely independently of the anterior glottis due to the three-dimensional rocking and sliding of the arytenoid bodies.
During inspiration, the entire glottis is in abduction. The electromyographic activity of the posterior ericoarytenoid muscle (PCA) is linked to that of the diaphragm. The PCA is activated 40 to 100 ms before the 864 inspiratory activation of the diaphragrn.":" PCA activity is also positively correlated with the activity of accessory inspiratory museles, such as the infrahyoid and intercostal museles. The cricothyroid muscle (CT) is also activated during inspiration, tensing the vocal folds.
Laryngeal adduction during expiration vari es according to lung aerodynamics. Adduction produces laryngeal resistance during expiration and thus increases intraalveolar pressure, which in turn improves gas exchange. Adduction seems to increase especially during physical effort. At rest, expiratory adduction may even be absent. Adduction during expiration is not obligatory, as tracheotomy bypasses the larynx with apparently no effect on alveolar gas exchange.'! Cough. Coughing is comprised of three phases: inspiration , compression, and expulsion. During the compression phase, thoracic pressure is increased by compression of expiratcry mu seles at constant volume due to laryngeal elosure. The maximum level of pressure attained, and thus the efficiency of the cough, depends in part on the quality of glottic occlusion. The cough reflex is inhibited during deep sleep, and thus laryngeal events such as gastropharyngeal reflux or aspiration may go unnoticed at night.'
Phonation. "Vocal fold vibration is the result of a delicate balance of subglottal air pressure driving the folds apart, and the muscular, elastic, and Bernoulli forees that bring them together.''" Laryngeal phonatory mechanisms are today in part explained by the "rnyoelasticaerodynamic" model developed by Dejonckere, Van den Berg, Faaborg-Andersen, Hirano, Titze, and others. Human phonation is thought to depend on four parameters: the state of the vocal fold, the state of the mucosa, glottic elosure, and subglottic pressure. Parameters defining the state of the vocal fold are the position in the axial plane, the level in the frontal plane, length, thickness, the size and shape of the medial edge, mass, and elasticity. The parameters describing the state of the vocal mucosa are tension, its viscoelastic properties, and the viscoelastic properties of the superficial lamina propria (Reinke 's space). Glottic elosure, or aerodynamic resistance, depends on the adduction of the membranous vocal folds and on the degree of elosure of the posterior glottis. Subglottic pressure is thought to be the aerodynamic driving force necessary for phonation. Current theory is based on the "body-cover" theory first described by Hirano.!' In this model, the "body" (the vocalis muscle) and the "cover" (the vocal mucosa) vibrate independently." In theory, the vibrations of the body do not interfere with those of the cover because of the isolating effect of the superficial lamina propria. Voice quality is thus the combination of these two vibrating structures, passively driven by the aerodynamic force of the subglottic pressure. Sensory or muscle-spindle For more information Circle 111 on Reader Service Card HARTL, BRASNU reeeptors have not been show n to play an aetive role in the initiation or the propagation of vocal fold vibration. Laryngeal reflex es. The laryngeal elosure reflex is elieited by stimulation of epicritical sensory reeeptors, ubiquitous but partie ularly rieh in the arytenoid mueosa and on the laryngeal surfaee of the epiglottis. The tonie laryngeal elosure usua lly reeedes spon taneo usly, but it is also inhibi ted by the hypoxemia ensui ng if glott ie elosure lasts a suffieient length of time. The elosure reflex is easi ly elieited at birth, beeo mes eve n more aetive during the first yea r of life, and then grad ualIy deereases in aetivity. The physiologie hyperae tivity of this reflex seems to be a faetor in sudden infant death syndrome. It is also implieated in paroxystie laryngospasm, in whieh the elos ure reflex is provoked by gas trop haryngea l reflu x from environmental irritation.' The elosure reflex also intervenes during vomiting.
Sensory laryngeal stim ulation, espeeially during endotraeheal intubation, ean also lead to bradyeardia, arrhythmia, and a fall in blood pressure due to parasympathetie vaga l-mediated reflexes. Certain laryngeal reeeptors are stimulated by negative pressure in the upper aerod igestive traet. Their stimu lation in obstruetive sleep apnea syndrome or upper airway resistanee syndrome may be a eause of eardiovaseular comp lications.
Glottie elosure oeeurs during the sneezing reflex and during hieeough, a eomplex reflex that remai ns poorly understood. Laryngeal elosure, reflex or voluntary, provides an inerease in abdominal pressure for defeeation and provides pressure-rnediated stab ilization of the thorax for lifting and other aetivities involving the arm s and shoulders.
Laryngeal innervation and neurophysiology
Central motor in nervation. Vaga l motor neuron eeli bodies are loeated in the brainstem in the ambig uous nueleus and in the retrofaeial nueleus. The dis tribution of motor neuro ns was first demonstrated by Gaeek in 1975 using the retrograde traeer horseradish peroxidase.!' The ambiguous nueleus is loeated lateral to the retieular formation of the eaudal brainstem, extending the entire length of the medulla oblongata. Its middle portion eontains the vagal motor neurons, with the larger adduetor neurons dorsalIy and the smaller abdue tor neurons (of the PCA musele) ventrally. The PCA neurons are fewer (by a faetor of 4) than the adduetor neurons and are more eompaetly arranged.
This dorsoventral arrangement paralleIs that of the respiratory ee nters in the brainstem. The expiratory center is situated dorsalIy, whereas the inspiratory center is loeated ventra lly in the reticular forma tion. The proximity of the laryngeal neurons to the respiratory neurons allows direet eonnee tion between them. The adduetor funetion is phylogenetieally the oldest, primit ive larynges havin g 866 only a eonstrietor funetion . The abd uetor funetion appears later in more advanced speeies. Its more reeent phylogenetie appearanee eould be the origin of a higher sensitivity of the abd uetor neurons to eentrallesions and explain bilateral ce ntral abduetor paralysis (or Gerhardt' s syndrome).
The retrofaeial nuele us is eaudal to the faeial nerve. It eon tains the motor neur on eeli bodies for the CT arranged perip herally, surro unding eeli bodies for the PCA loeate d eentrally.
In summary, CT and PCA innervation arise in the amb iguous and retrofaeial nuelei, whereas adduetor innervation arises only in the nueleus ambiguous. Laryngea l innerva tion is ipsilateral; no cross-innervation arises direet ly from these motor neurons." :" :'?
Current conc epts iil laryngeal innervation. Cortical regulation. There seem to be a eertain number of direet or indiree t eon neetions between the ambiguous nueleus and eertain cen tral areas---espeeially Broea' s area , the motor eortex, and the anterior eing ulum-but their sig nifieanee is poorly understood.
Subcortical regulation: periaqueductal gray matter. The periaqueduetal gray matter (PA G) deseribes a partieular subeortieal array of neurons loeated adjaeent to the aqueduet of the fourth ventrie le. It has been studied extensively in the eat and monkey.'? The neurons reeeive affere nees from the limbie system and the eingulum. Efferenees exte nd to the ambiguous nueleus , the nueleus of the solitary traet (sensory), and to resp iratory eenters in the brainstem.
Th is neuronal formation seems to play an important role in reflex voea liza tion (pain, danger) in the speeies studied. Stimulation studies in animaIs have also shown a central analgesi e effeet, with endorphin produ etion following stimulation of the PAG. It has been hypothesized that this region eould be responsi ble for endorp hin liberation in eer tain types of human voea liza tion, such as lamenting and erying, exp Iaining the eathart ie effeet of human expressions."
Brainstetn regulation. Some studies have evoked the existenee ofbilateral eonneetions between laryngeal motor neurons in the brainstem, but this has not yet bee n proven. The ambiguous nueleus is thought to reeeive afferenees from the eontralateral ambiguous and retrofaeial nuelei as weil as bilateral signals from the nueleus of the solitary tract .'?
Interactive organization of laryngeal control. The eerebra I eortex intervenes with a high level of plastieity in the various lary ngea l aetivities. Subeortieal struetures (striatum, eorpus eallosu m, globus pallidus, thalamus, and eingulum) see m to intervene bilaterall y in voiei ng, for only bilateral subeortieal lesions lead to lasting loss of voice. The eor tical regulation, however, seems to be situated in the domi nant hemisphere, as a unil ateral T he different types oflaryngeal aetivity-erying , whi spering, singing, eoughing, ete .-appear to have a speeifie and dis tinet eor tieal representation . Th e fibers from eaeh eortieal laryngeal "center" eonverge in the nucleus ambig uo us . It seems that eaeh type of laryn geal ae tivi ty has a "code" of neuronal sti muli , varying by origin, ehronology, frequeney , and intensity . Th ese different "codes" translated in the nucleus ambiguous would produee a variable effeet on the laryngeal museul ature, leading to different types of laryngeal aetivity . Spasmo die dysphonia is an empirie example of this central "coding" of laryngeal aetivity in that, in general, the spasms oeeur only for a speeifie type of laryngeal aetivity, usuall y speaking. T he spasms are often absent during other types of laryngeal aetivity, such as whispering, shouting, or sing ing.
Th e variable laryngeal muse le aetivity may also be regu lated by inhibiting interneurons (a brai ns tem eq uivalent of the Renshaw interneurons in the spinai cord). T his remains to be more fully elueidated.
In eonclusion, experimental evi denee exists to show that voieing eon tro l is more eomplex tha n a simple vo luntary mechanism. '?
Peripheral motor innervation Axolls. The motor innervation of the larynx is supplied by the Xt h era nial nerve, the vag us nerve. The motor axons leave the ambiguous and retrofaeial nuclei , co mbine, and form one or two rostral roots for the vagus nerve.'?
Axons from the ambig uous nucleus have a larger cireumferenee than the retrofaeial axo ns . It has been shown for ske letal musele that large-diameter fibe rs pro voke rapid and short muse ular eo ntraetions eorrespondi ng to fas t-twitch mu seu lar fibers (type II). Small-diameter fibers eorrespond to slow -twiteh muscle fibers (type I) . T he do uble origin, ambiguous an d retrofaeial, of the PCA and CT are refleeted in their mixed mu seul ar type. Type I and type II fibers eoe xis t in these muscles, but they are classified into di stinet groups." T his duality may play a role in the different funetions of these muscles, wit h fatigue-resistant eon traetion for abduetion during breath-Reach More Patients. ing and rapid contraction for adduction and tensing of the voca l folds during phonation. "
Axons for the recurrent laryngeal nerve are all mye linated and remain gro uped together alo ng the entire length of the vagus nerve . Abductor and adductor fibers are randomly dispersed . In the cranial portian of the vagus nerve, the "recurrent" fibers are in the anterior part of the nerve. They turn toward the medial aspect of the nerve as the vagus descends caudally. The rec urren t nerve separates fro m the vag us at its med ial aspect. The abductor and adductor fibers separate several cen timeters before en tering the larynx (in the cat). Thus, Semon' s theory of the greate r anatomic vulnerability of abductor fibers as compare d with adductor fibers seems to be false (see below).
The vagus nerv e. The vagus ner ve originates at the anterolatera l surface of the medull a oblongata. The superior (jugular) ga nglion of the vag us nerve is situated close to the origin of the nerve and co ntains the cell bodies for sensory and parasympathetic fibe rs. The vagus nerve the n leaves the cranium at the skull base via the jugular foramen anterior to the internai jugular vein. Th e nerve follow s the posteromedial surface of the vein to the plexiform ganglion, from which arises the superior laryngea l nerve . Along the posteromedial surface of the internai jugular vein , the vagus contributes to and receives anastomoses from the carotid sympathetic chai n. On the left side, the vagus follows the posterior surface of the common carotid artery and crosses the anterior surface of the aortic arc h. Th e recurrent nerve branc hes under the aortic arch , runs medially under the aorta, and then return s cra nially in the tracheoesoph ageal groove. On the right, the vagus nerve follows the posterolateral surface of the common caro tid artery to the bifu rcation of the brachi ocep halic artery . The rec urrent nerve branches off under the subelavian artery, runs medi ally along the pleur a, and the n returns cra nia lly beh ind the common caro tid artery in fron t of the vertebral arte ry toward the tracheoesop hageal groove ."
The recurrent laryngeal nerve. Thus, on the left, the recurrent laryngeal nerve (RLN) has an intra thoracic portion, vul nera ble to cardiothoracic or mediastinal pathology. In its cerv ical port ion, the nerve runs cran ially behind the left lobe of the thyroid gland, under the inferior phary ngeal co nstrictor muscle, and penetrates into the larynx behind the cricothyroid joint between the thyroid ala and the cricoid lami na. Some reports refer to the intralaryngeal portian of the nerve as the infer ior laryngea l nerve, but we will continue to employ the term RL N. The RLN has an anterior motor branch and a posterior sensitive branch. Th e latter runs deep to the piriform sinus mucosa to for m an anastomosis with the internai branch of the superior laryngeal nerve (Ga len's anastornosis),
The right RL N run s obliquely from the subelav ian arte ry, behind the right thyro id lobe, laterai to the trache-868 oesophagea l groove. The laryngeal pene tration, bifurcation , and subd ivisio ns are the same as the left RLNY The anatomy of the cervical portian of the RL N may vary . Extra laryngeal division before entering the larynx has been observed in 35 to 80% of cases reported in the literature." The RL N may be "nonrecurrent ," branching from the cervical portian of the vag us nerve , Its relatio nship with the thyroi d arteries is varia ble. On the left, the RLN is said to run posterior to the branch es of the infer ior thyroi d artery. On the right, the nerve is said to run anter ior to the inferior thyroid artery. In truth , their relative posi tio ns are highly variable.
The microvascul arization of the RLN is princip ally supplied by a posteri or branch of the inferior thyroid artery or, mar e rarely, by the thyroid irna artery, a branch of the aor tic arch, or the brachi ocephalie artery at the anterior surface of the trachea.
Th e RLN co ntains 500 to 1,000 motor axons, of which 250 are destined for the PCA musele. In cats, the right RL N contains mare axons than the left RLN .19 Two centimeters cauda l to the laryngeal penetration (in cats), 50 % of the mye linated fibers are motor axons. At the point of entry, however, 80% are motor axons. Between these two points, the RL N gives off numerous tracheal and esophageal sensory fibers. The remaining 20% of mye linated fibe rs are sensitive fibers. Th e nonmyelinated fibers in the RLN are sympathetic caro tid plexus fibers and parasympat hetic postganglionic dendr ites, whose cell bodies Iie in the superior j ugular and plexiform ganglions.'? These nerve fibers innervate laryngeal blood vesseis and submucosal glands.
Ex ternal branclt of the superior laryngeal nerve.
Current theory hold s that only the externa l branch of the superior laryngeal nerve (SLN) has motor activity, and only for the CT. Recentl y, however, the deb ate has been reo pened inas much as anasto moses between the RLN and the internaI branch of the SLN have been observed, which could explai n the variab ility of the voca l fold positian in RLN para lysis (see below). The SL N arises at the inferior extremity of the plexiform gang lion. It run s posterior and media lly to join the upper phary ngea l constrictor, whic h it follows inferiorly to the greatercornu of the hyoid bone.
Here the SLN div ides into an external and an interna i branch. The external branch runs along the laterai surface of the middle and infe rior constrictor, provides the motor innervation for the two bellies of the CT , perforates the cricothyroid me mbrane, and assures the sensory innervation of the anterior subg lottie region." The interna i braneh of the SLN pen etrates immediately thro ugh the thyrohyoid membrane. Its intralaryngea l bra nching is described below . 
Intralaryngeal motor innervation
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• MT! Mode1423, full power 24 volt DC treatment chair with electric swivel lock and dual programmability. • TC75 "Ultra" Treatment Cabinet • õ-Caster Stool "for$160 achairmounted light can beadded. strated the intramuscular innervation of the laryngeal muscles." The RLN divides into an anterior (motor) branch and a posterior (sensory) branch. The first branch of the motor divisi on is destined for the PCA. The seco nd innervates the interary tenoid muscle (lA) after runnin g posterior to the cricoarytenoid joint and deep to the PCA. The lA is inne rvated by both RLN. 26 The third motor branch innervates the lateral cricoary tenoid muscle (LCA), passing thro ugh it to terminate in the thyroarytenoid muscle (TA) . There are multiple terrninal branches of the RLN in the TA , in the ventricular fold (superior TA muscle), and in the aryepiglottic muscle. The terrnin al branche s have the highest density along the medial aspect of the medial TA (or vocalis muscle ). The external branch of the SLN innervat es the CT, continues its course through the CT, the TA, and then termin ates on the inferior aspec t of the voca l proce ss of the arytenoid.
Anastomoses between terrninal branches of the RLN and the SLN have been observed. Branches of the internaI branch of the SLN connect with branches of the RLN in the lA muscle." The functio n of the nerve endings from the SLN in the lA is stiil unkno wn. They may correspond to proprioceptive muscle receptors, although their communic ation s with fibers from the RLN imply a motor function .P-" Motor function has yet to be demon strated , however. The communicating nerve, originating from the externa l branch of the SLN, runs through the CT and deep to the piriform sinus to form an anas tomosis with a terrninal branch of the RLN in the TA muscle. The commun icating nerve is thought to be the nerve of the fifth branchial arch." In dogs, a motor function of the com municating nerve has been demonstrated." In the study by Sanders et al, no left-right anastomoses were observed."
In summary, anastomoses between the RLN and the SLN exis t, although their role is currentl y unkno wn and motor activity has yet to be proven. The effect of the bilateral innervation of the lA on laryngeal configuration is also unknown. The organization of the muscular branches of the RLN reflec t the anato my of these muscles, arranged in distinct bellie s, and organized by muscle fibertype.The complex terrninal branching throughout the muscles reflects their multi -innervated nature (see below) and is particul arly dense in the vocalis muscle.
Innervation of muscle fibers
Laryngeal muscle fibers differ microscopic ally from other skeletal muscle. Like other skeletal muscles, each fiber has a mononeuronal innervation; innervation for that fiber arises from onlyone axon, and thus from onlyone neuron." The polyneuronal innerva tion found in feta l skeletal and laryngeal muscle disappears at birth. Laryngeal muscle is different in that there are several motor end plates per muscle cell(the fiber s are multi -inner vated). This particular characteri stic is shared with the extraocu-870 lar muscles and may be a factor allowing for more rapid or more sustained contractions. In addition, motor end plates are dispersed throughout the muscles instead of occupying onlyone specific site. Th is may be due to the wide insertions of the laryngeal muscles along the laryngeal cartiIages and the lack of tend ons as with other skeletal muscle," and it may also play a role in rapid muscular contraction.
General neurophysiology
Anatomy of periplzeral nerves. Periph eral nerves are comp osed of nerve fibers (axons and dendrites), supporting cells, and connective tissue. More than 50 % of the nerve is, in fact, conn ective tissue cont aining collagen, elastic fibers, and extracellul ar fluid s." The nerve fibers are enco mpasse d by four different envelopes. The most peripheral laye r is the mesoneurium , a thin transparent layer of con nective tissue that attaches the nerve to surrounding tissues. Thi s loose layer allows the nerve to slide with movements of the surrounding structures and provides an easily dissectable plane. The next outermost layer is the epineurium, a dense white covering of collagen and elastic fiber s. Thi s layer gives the nerve elasticity; a certain amount of stretching can occur without damage to the nerve fibers within. This dense layer allows for precise suturing during nerve repair without dama ge to nerve fibers. Inside the epineurium, the nerve fibers (or neurites) are gro uped into bundles. Each bundIe, or fascicle, is surrounded by perineurium, a layer of cells with tight jun ctions resting on a peripheral basal membrane, which in turn is surro unded by several dense layers of collage n in a circ ular and longitud inal array. Epineurial conne ctive tissue holds the fascicles together. The fascicle is the smallest unit of the nerve visible using the operating microscope, and perineuri al sutures are possible. The imperme able nature of the perineurium is an efficie nt barrier agai nst infection, neoplastic encroachment, and inflammation. The endoneur ium, a loose connective tissue, is the fourth layer surro unding the neurites.
Each axon is surro unded by Sch wann cells, which produce the myelin sheath. Each cell rests on a basement memb rane. Ranvier ' s nodes are small spaces between Schw ann cells. For well-myelinated, generally largediameter fiber s, the depolarization of the axonal membrane "jurnps" from node to node, resulting in a rapid conduction rate. Less well-rnyelinated fibers, generally of smaller diameter (nociception or autono mous nerves), have a slower conduction rate because the depolarization runs along the entire length of the fiber and cannot jump.
Each nerve fiber changes its position in the nerve every few centimeters, moving in the fasci cle and even changing fascicles. Nerve vascularization is provided by a network of small, interconne cted blood vesseIs runnin g longitudin ally inside the epineurium and the perineurium. When it comes to post-surgical care... Th is provides a relative resistance to surgical devascularization." Nerve growth and regen eration. Tr auma to a nerve results in a degenerative phase followed by regeneration." Axonal degeneration is retrograde, the axo n shrinking back toward the neuronal cell body. The myelin and endone urium left behind are phagocyti zed by cells involved in the infla mmatory response . The proliferation of neural envelope cells follo ws the degeneration . The Schwann cells proliferate along their basal membrane and direet the longitudinal regrowth of the axon. Schwann cell proliferation is nece ssary for linear axonal regrowth in the right direction. It has been postulated that Sch wann cell s produce neurotrophic factor s, but the mech anism of their effect on the neural cyto skeleton is unknown. An exaggerated proliferati on of fibroblasts may block the line arly organized proliferation of Schwann cell s, resultin g in a neuroma-a chaotic mix offibroblasts, collagen, Schwann cells, and neurite s.
weve got the right solution!
Neural regro wth occurs distally toward the proximal end of the distal ner ve segment, even if there is a long space separati ng the two ends. The distal seg ment seems to produce factors that attract the grow ing nerve, but the mechanism is curren tly poorly understood. It is also thought that denervated muscle produc es neurotrophic factors."
In the central nervous system, the neur al cell body undergoes chromatolysis with peripheral shifting of the Nissl bodie s (stocked metabolite s) and a decrease in their number. The cell body grows larger and incre ases its metaboli sm, as shown by a major increase in RNA. It seems that synaptic functi ons decre ase during this phase of regeneration and metabolic reorganization.
After injury , changes in the central neural control may occur. Peripherally, clo se to the dama ged tissue, undamaged adjacent nerve fibers can migrate and reinnervate the damaged tissues , resultin g in innervation by a different neuron than before the injury. Thi s has been observed for sensory and mot or nerves, especially in the case of amputation."
Types of neurai injury
One macroscopic type of nerve injur y can in fact produce severa l different microscopic types of neurite damage.
Neurapraxis. Neurapraxis (nerve "shock" ) results simply in a co nduction block along the neur ite. The cell memb ranes of the nerv e fibers and the nerve envelopes remain intact. Th e macroscopic mechanism is generally compress ion or excessive stretching. Large-di ameter myelinated fiber s (motor, sensory) undergo the most damage. Auto nomic and nocicepti ve nerves are less damaged, and pain may occur after neur apraxis. Detecti on electromyography (EMG) is abnorm al, reflecting the paresis and/o r the hypo esthesia. Stimulation-detection 872 EMG , however, is normal, for the neuron is intac t. Spontaneous recovery occ urs after severa l days to several weeks."
Axonotmesis. In this case , the nerve fiber and its myeli n sheath are cut , without interruption in the neuraI envelopes. Again , it is generally caused by violent com pression or stretching. Nerve conduction is interrupt ed and the nerve fiber undergoes retrogra de degeneration (Wallerian degeneration). Dete ction EMG shows fibrillation potentials, a sign of dene rvation. Stimul ation-d etection EMG obtains no respon se. The dege neration phase begins 3 to 7 days following the damage and lasts several wee ks. Ner ve fiber regrowth then occurs at a rate of appro ximately I mm per day. The neurite must recuperate the distance lost durin g the degeneration phase, cros s the site of the initial lesion , penetrate into the rem aining distal envelopes, and cont inue all the way to the nerve endin gs. Dur ing this phase, stimulation-detection EMG shows potentials with increased latency and small amplitude.
The axon arrives at the motor end plate and sprouts nerve endings, but voluntary muscular contrac tion may still not be possible due to a "maturation" phase involving nerve, end plate, and muscle.
Neurotmesis. Neurotmesis is the interruption ofneurites, myelin, and the nerve envelopes (at least the endoneurium and the perineurium, in crush inj ury, for example). Wallerian degeneration and then nerve regrowth occur in much the same way as after axo notmes is, with two differences . First, regrow th of the envelopes may occur in a chaotic manner, result ing in a neurom a-a disorg anized mix of fibroblasts, collage n, elastic fiber s, perin eural cells, Sch wann cell s, and neur ites. The seco nd differenc e is that even the neurites that have crossed the site of the initi allesion tend to have a smaller than norm al diameter and a poor-qu ality myelin sheath, and thus functi on poorly."
Sunderland's classification. Much of the currentknowledge of peripheral nerve anatomy and physiology was observe d by Sunderl and , who develop ed the following classifica tion for periph eral nerve lesion s: grade I, neurapraxia; grade II, axono tmesi s; grade III, mixed neurapraxic and axo notmetic lesion; grade IV, neurotmesis with continuity of the epineurium; grade V, complete ner ve section."
In general, types I and II usually begin to show spontaneous EMG activi ty after approximately 6 weeks. In the other cases, recup eration is unpredictable.
RLN regrowth
Depending on the microscopic lesions occ urring in the RLN, seve ral sce narios are possible. For pure neurapraxic lesions (after thyroid ectomy for benign pathology, for exa mple), larynge al pare sis will occur. Paresis may not even be detected clinicall y, and the nerve generally recu- tatss-positlve reaetion for glueose in the urineusing Clinitests••, Benediet's solution, or Fehling's solution. It is reeommended thatglueose tests based onenzymatie glueose oxidase reaetions (such as ClinistiXO · · or Tes-Tape· · · ) be used. A lalse-positive direet Coombs test has been reported during treatment with other eephalosporin antibioties; it shouldberecognized that a positive Coombs test may be dueto the drug. Careinogenesis, MUlagenesis, Impairmenl al Fertllily: Lifetime studiesin animalsto evaluate carclnogenie potenti al have not been conducted, SUPRAX did not eause point mutations in baeteria or mammalian eelis, DNA damage, or ehromosome damage in vitro anddid not exhibit elastogenie potential in vivo in themouse mieron ueleus test. In rats, lerlility and reproductive performance were not alleeted by eelixime at doses up to 125 times the adult therapeutie dose. Usage in Pregnaney: Pregnan ey Category B. Reproduction studi es have bee n perlormed in miee and rats at doses up to 400 limes thehumandose and have revealed noevidenee 01harm to the fetusdue to SUPRAX. There are no adequate and well-eontrolled studiesin pregnant women. This drug shoul d be used during pregnancyonly il elearly needed. Labor and Delivery: SUPRAX has notbeen studied for use during labor and delivery. Giveonly if elearly needed. Nursing Molhers: It is not known whether SUPRAX is exereted in human mil k. Consider diseontinuing nursing temporarily during treatment. Pedialrie Use: Salety and etleetiveness01 SUPRAX in ehildren aged less than six months old have not been established. Th e incidenee of Gl adverse reaetions, ineluding diarrhea and laose stools, in pediatrie patients reeeiving the suspension, was eomparableto the ineidenee seen in adult patients reeeiving tablet s.
ADVERSE REACTlONS:
Most adverse reaetionsobserved in eli nieal trials were01 a mild and transient nature. Fi ve percent 01 pati ents in the U.S.trial s di seontinued therapy beeause 01 drug-relat ed adve rse reaetions. Themost common adverse reaetions in U.S. trials 01the tablet lormulation were Gl events, whieh were reported in 30% of adult patients on either the BIDor the ODregimen. Clinieally mild Gl side etleets oeeurred in 20% ofallpatients, moderate events in 9%, and seve re adve rse reaetions oeeurred in 2% 01 all patients. Individual event rates ineluded diarrhea 16%, loose or lrequent stools 6%, abdominal pain 3%, nausea 7%, dyspepsia 3%, and flatulenee 4%. The incidenee 01 Gl adverse reaetions, includi ng diarrhea and laose stools, in ped iatrie patients reeei vingthe suspension was eomparable to that see n in adult patients reee iving tablets. Symptoms usuall y respanded to symptomatie therapy or eeased when SUPRAX was diseontinued. Several palients developed severe diarrhea and/or doeumented pseu domemb ranous eolitis, and a few requi red hospit alization.
The following adve rse reaet ions have bee n reported following the use of SUPRAX. Incidenee rates were less than 1 in 50 (Iess than 2%), exeept as noted above tor Gl events. Gl (see above): Diarrhea, laose stcols, abdominal pain, dyspepsla, nausea, and vomiting. Several cases of doeumented pseudomembranous eoli li s were identil ied during the studies; onset 01 symptoms may oeeur duri ng or alter therapy. Hypersensilivily Reaellons: Skin rashes, urliearia, drug fever, and pruritus. Erythema muitiforme, Stevens-John son syndrome, and serum siekness-Iike reaetions have been reported. Hepalle: Transient elevations in SG PT, SGOT, and alkaline phosphatase. Renaf. Transient elevationsin BUN or ereatinine. CentralNetvaus System: Headaches or dizziness. Hemi e and Lymphatie Systems: Transient thromb oeytopenia, leukop enla, and eosino philia. Prolongalion in prothromb in time was seen rarely. Dther. Genital pruritus, vaginitis, eandidiasis.
In additionto the adverse reaetions iisted above whieh have been observed in pat ients treated with SUPRAX, thefollowing adverse reaetions and altered laborato ry tests have been reporled lor eephalosporin-el ass ant ibioties: Adverse Reaetions: Allergie reaetions ineludi nganaphylaxis, toxie epidermal neerolysis, super infeetion, renal dysfunetion, toxie nephropathy, hepatie dysfunetionineludingeholestasis, aplastie anemia, hemol ytieanemia, hemorrhage, and eolitis.
Several eephalosporins have been implieated in triggering seizures, parlieularly in patients w~h renalimpairment whenthe dosagewas notreduced, (See DOSAGE AND ADMINISTRATION in full Preseribing Information, and OVERDOSAGE.) It seizures associated with drug therapy oeeur, the drugshould bediseontinued . Ant ieonvulsanttherapyean be given if elinieally indieated. Abnormal Laboratory Tests: Positive direet Coombs test, elevated bi lirubin, el evated LDH, paneytopenia, neutropenia, agra nuloeytosis.
OVERDOSAGE:
Gastrie lavage may be indieated ; otherwise, nospeeifie antidote exists. Cefixime is not removed in signilicant quanlili es from theeireulation by hemodialysis or peritonealdialysis. Adverse reaetions in small numbers of healthy adult volunteers reeeiving single doses up to 2 9 of SUPRAX did not diil er Irom the profile seen in patients treated at the reeommended doses. the usual drug 01choice in the treatment ot S. pyogenes inteetions, ineluding the prophylaxis 01 rheumatie lever. SUPRAX is generally elleetive in the eradieation of S. pyogenes Iromthe nasopharynx; however, data establishingtheellieaey 01SUPRAX in the subsequent prevention 01 rheumatie lever are not available. Uneomptieated Urinary TTael fnfeelions eaused by Eseheriehia eoti and Proleus mirabilis. Uneomptieal ed gonorrhea (eervieal/urethral) eaused by Neisseria gonorrhoeae (pen ieillinase-and nonpenieillinase-produeing strains). Appropriate eultures and suseeptibility studies should be perlormed to determine the eausative organism and its suseeptibility to SUPRAX; however, therapy may bestarred whileawai ting the resui ts 01these studies. Ther apy should be adjusted, il neeessary, onee these resuits are known. · Ell ieaey lor this organism in this organ system wasstudied in lewer than 10 inleetions.
CONTRAINOICATIONS:
In patients with known allergyto the cephalosporin group 01antibioties. Administer antibioties, ineluding SUPRAX, eautiously to anypatlent who has demonstrated some torm ot allergy, parti cularly to drugs. Treatmentwith broad-spectrum antibiot ies, ineluding SUP RAX, ai ters the normal flora ot the eo lon and may permi t overgrowth ot elostridia. Studiesindieate that a toxin produeed by Clostridium diffieile is a primary eauseof severeanti biotie-assoeiated diarrhea ineluding pseudomembranous eolitis.
Pseudomembranous eolitis has been reported wi th the use ot SU PRAX and otherbreadspeetrum antibioti es (ineludingmacrolldes. semisynthetie penieillins, and eephalosporins) ; theretore, it is imporlant to eonsider this diagnosis in patients who devel op diarrhea in association with the use ot ant ibioties. Symptoms 01 pseudomem branous eolit is may oeeurduring or alter anti biotie treatment and may range in severi ty Irom mild to lilethreatening. Mild cases of pseudomembranous eolitis usually respond to drug diseont inuationalone. In moderate to severecases, managementshouldineludeIluids, eleetrolytes, and protein suppleme ntation. II the eolitis does not improve alter the drug has been diseontinued, or if the symptomsare severe, oral vaneomyein is the drug of choice for antibiotie-assoeiated pseudomembranous eolitis produeed by C. diffi eil e. Other eauses 01 eoli tis shoui d be exel uded. perates spontaneously in several days or weeks. For pure axonotmesis, nerve regeneration will have a longer delay, and the resulting muscular contractions may be of poorer quality than before. In theory, however, each axon regrows along its previous envelopes and reaches the same motor end plates as in its previous state. Neurotmesis is the interruption of the fibers' envelopes, even with immediate termino-terminal anastomosis and even if just the endoneurium and perineurium are interrupted without epineural effraction. The risk is misdirected regrowth of nerve fibers. If a neuroma forms, the axons never reach the laryngeal muscles. Laryngeal paralysis is theoretically total. Detection EMG shows fibrillation potentials (denervation) and then electrical silence. After approximately 3 weeks of denervation, the muscles undergo denervation atrophy and disorganization of the muscle cell structure, and then fibrosis and/or adipose transformation. Muscle degeneration is thought to be complete after 2 to 3 years.
Axonal regrowth may reach the laryngeal motor end plates, with several possible outcomes. First, voluntary contraction is never attained, but reinnervation is sufficient to prevent denervation atrophy. Second, the reinnervation may be of poorquality due to small fiber dimension or to insufficient maturation of the motor end plates. This may lead to isometric muscular contraction without a global vector of motion. Third, axons may grow in a misdirected fashion and reach motor end plates that they initially did not innervate. Adductor fibers may innervate abductor muscles and vice versa. The simultaneous contraction in antagonist muscles that results is called "synkinesis. " 35 Synkinesis depends on the quantity and the quality of the reinnervation of the antagonistic muscles and the equilibrium or disequilibrium in reinnervation that has occurred. Equilibrated synkinesis can lead to a neutraI position of the arytenoid without anteromedial rocking and a paramedian vocal fold position without vocalis muscle atrophy. Small trembling-like movements may be detected. This laryngeal configuration generally results in a good vocal result and is considered "favorable synkine-SiS."36 Disequilibrated synkinesis can lead to spasmodic or paradoxical motion of the arytenoid and the vocal fold. Spasmodic dysphonia and/or spasmodic stridor may occur. This is considered "unfavorable synkinesis .?"
A second phenomenon has been evoked to explain apparent misdirected reinnervation. Ephapse is the mutual stimulation of two regenerating neurites, with myelin sheaths of poor quality, like two electrical wires that have lost their plastic coating ." Normal myelin (and the other neural envelope layers) act as an electrical barrier, insulating each fiber. The poor quality of the myelin may result in cross-stimulation of adjacent nerve fibers.
Central reorganization has been demonstrated after Volume 79, Number 11 nerve damage in limbs . Misdirected nerve fibers obtain a new function according to the muscle reinnervated. In some cases, the neuron cell body changes its central connections according to this new function in an adaptation mechanism. However, this adaptation may be incomplete, and voluntary solicitation of the "old" function may produce parasitic motion in the new ly innervated muscle. Central reorganization has not yet been demonstrated for neurologic lesions of the larynx. RLN lesions can also be mixed, axonotmetic, and neurotmetic. In this case, axons having retained their envelopes (perineurium) will reinnervate the same muscles as before the damage. The other axons may undergo misdirected regrowth with synkinesis. The variable association of these two mechanisms could explain some of the variability in laryngeal configuration after RLN damage. Parti al residual normal innervation from neurapraxia may also coexist with more severe lesions and could also contribute to laryngeal configuration in some cases."
Van Lith-Bijl et al compared the evolution of RLN damage by compression and by section-anastomosis in a feline model." Signs oflaryngeal motion appeared earlier aftercompression of the RLN (axonotmesis). EMG activity in the PCA and TA muscles appeared earlier and abduction was of greater amplitude. Synkinesis was detected on EMG more frequently following nerve section, despite surgical anastomosis. The number ofaxons present distal to the lesion site was, however, the same for both types of neural damage.
Evidence for synkinesis. Flint et al, in their seminal
article coneerning laryngeal reinnervation in the rat, provided an elegant demonstration of misdirected nerve growth.'? They employed horseradish peroxidase as a retrograde tracer to follow axons corresponding to laryngeal muscles after unilateraI section-anastomosis of the RLN . Normally, the adductor neurons corresponding to the TA and the LCA are located lateraI and dorsal to the abductor (PCA) neurons. Following section-anastomosis , this clear organization disappeared; the neurons corresponding to the TA, LCA, and PCA were arranged haphazardly, although with a predominance of neurons in a lateraI and dorsal area. In addition, labeling was weaker than in normal rats. No labeling in the contralateral brainstem was observed. Finally, up to 15% of the neurons labeled for both the PCA and the TA/LCA, meaning that the same axon had branches for the adductors and for the abductor. EMG in the experimental rats showed phasic inspiratory activity in the PCA, but also in the TA and the LCA , normally electrically silent during breathingo These observations imply a nonselective, misdirected reinnervation of the laryngeal muscles. The reinnervation seemed to be predominantly assured by the adductor fibers, four times more numerous than the abductor fibers in the RLN. 16 .34 Other studies involving 875 limbs and the facial nerve have shown that selective reinnervation may occur after section-anastomosis, but only in the cas e of very young animals."
In summary, synkinesi s-the simultaneous contraction of adductor and abdu ctor muscles-seems to originate from misdirected regrowth of motor axons. A single motor neuron can innerv ate both an abductor and an adductor muscle follow ing misdirected regrowth . Reinnervation seems to be assured for a major part by adductor fiber s (at least in the rat Alter dai ly oral doses of 750 mglkg (miee) and 250 mg/kg (rats) were administered for up to 2 years,therewas no evi denee that eiprolloxaein hadanyeareinogenieor tumorigeni eeffeets in these speeies. Nolong term studies of CIPRO' HC OTICsuspension have beenpertormedto evaluate earei nogenie potential. Fertili ty studiesperformed in rats at oral doses of eiprofloxaein upto 100 mglkg/day reveal ed no evidenee 01 impairment. This would beover 1000 times the maximumreeommended elinieal dose of ototopieal eiprolloxaein based uponbody surfaee area, assuming total absor ption 01ei profloxaei n from the ear of a pati ent treated wi th CIPRO' HC OTICtwiceperday. Long termstudies have not been performedto evaluate theeareinogenie potentialor theeffeet on lertility 01 topieal hydroeortisone. Mutageni eity studieswith hydroeortlsone were negative. Pregnaney: Teratogenie Effeets. Pregnaney Gategory C: Reproduction studies have beenperformed in rats and miee using oral doses ofupto 100 mglkg and IV doses upto 30 mglkg andhave reveal ed noevidenee 01harm to the letusasa result of eiprof loxaein. In rabbits, eiprofloxaein (30and 100mglkg orally)produeedgastroint estinaldistur· banees result ing in mat ernai weight loss andan inereasedineidenee 01 abortion, butno teratogenieitywas observed at eit her dose. Affer intravenousadministrationof doses upto20mglkg, no maternai toxieity was produeed in the rabbit, and no embryotoxieity or teratogenieity was observed. Cortieoste roids aregenerallyteratogeniein laborataryanimalswhenadministered systemieallyat rel atively lowdosage leveis. The more potent eortieosteroidshave beenshown to beteratogenie alierdermai applieation in laborat ory animals. Animal reproductionstudies have notbeeneonduetedwithCIPRO' HC OTIC. Noadequa teandweil eontrolled studies have been perf ormedin pregnant women. Cautionshould be exereised when CIPRO' HCOTlCis used bya pregnantwoman. Nursing Mothers: Ciprofloxaein is exereted in humanmllkwith systemie use. It is not known whether elprofloxae in is exereted in humanmil k foll owingtopieal otie administration. Beeause of thepotential for serious adverse reaetions in nursing infants, a deeision should be made whetherto diseontinue nursing or to diseont inuethedrug,takinginto aeeount the importanee of the drugto the mother. Pedlatrie use: The safety and effieaey of CIPRO' HC OTIC have beenestablished in pediat rie patients 2 years and older (131 patients) in adequate and well-eontrolled eli nieal trial s. Although no data areavailable onpatlent s less thanage2years, thereare no known safetvcon· eems or differenees in thedisease process inthis populati onwhieh would preeludeuseof this produetin pati ents oneyear and older. See DOSAGEAND ADMINISTRATION . Streptocoeeus (Viridans Group)"°E liicacy fortheseorganisms was studied infewer than 10inleetions. CDNTRAINDICATIDNS: Ahistory ofhyper sensitivitytoeiprofloxaeinorany other eomponent ofthe medlcation is a eontraindication to itsuse. A history of hypersensitivity to other quinolones may also contraindicatethe use01 ei profioxaein. WARNINGS: NOTFORINJECTlONINTO THEEVE. Serious andoecasionally latalhyper senshivity(anaphylaetie) reaetions,some followingthefirst dose, have beenreportedinpatientsreeeivlngsystemie quinolonetherapy. Some reaetionswere aeeompanied bycardiovaseulareollapse, loss of eonseiousness, tingling, pharyngeai orfaeial edema, dyspnea, urt icaria, and itehing. Only a few patients had a history of hypersensitivity reactons, Serious anaphyiaetie reactons requireimmediate emergency treatment with epinephrine andother resuseitationmeasures, ineluding oxygen,intravenous fluids, intravenousantihistamines, eortieosteroids, pressor amines and airway management, as elinicallyindieated. Removeeontaet lenses before using. PRECAUTIONS: General: Aswith other antibaeterial preparations, prolonged use of eiprofloxaein may result in overgrowth 01 nonsuseeptible organisms, ineluding fungi. If superntecnon oeeurs, appropriate therapy should be initiated.Whenever elinical judgment dietates, the patient should be examined with the ai dof magnilication, such as siitlamp biomieroseopyand, where appropriate,Iluoreseeinstaining. Ciprofloxaeinshouldbe diseontinuedatthe firstappearanee 01 aski nrash orany other signofhypersensit ivity reaetion. Ophthalmlc ointments may retard comeal healing and cause visual bl urring. Patients shouldbe advised nottowear eontaet iensesil they havesigns and symptoms 01 baeterial eonjunetivitis. Inelinical studies ofpatients with baeterial comeal uleer,awhite crystalline preeipitatelocated inthe superfieial portion ofthecomeal deteet was observed in35(16.6%) of210patients. Theonset 01 theprecipltatewas within24hours to 7 days aner starting therapy. In one patent, thepreeipitate was immediately irrigated out uponitsappearanee.ln17patients, resolutionofthe preeipitate was seen in1to8days (seven wi thi nthelirst24-72 hours), in fivepatients, resolution was noted in 10-1 3 days.ln nine patients, exaet resolution dayswere unavailable; however,atfollow-upexaminations, 18-44days alier onset 01theevent, eomplete resoiution01 thepreeipitate was noted. Inthree patients, outeome inlormationwas unavailabl e. Thepreeipi tate did not preeludeeontinued use ofeiprofloxaein, nordi ditadversely alieet the elinieal eourse of the ul eer orvisual outeome. (SEE AOVERSEREACTIONS). Information lorpatient s: Donot touehtiptoanysurtaee, as thismay eontaminate the produet. Drug Interaetions: Speeifie drug interaction studies have not been eondueted with ophthalmie eiprolloxaein. However,the systemie administration 01 some quinolones has been shown to elevate piasmaeoneent rationsoftheophylline, int ert erewiththemetabolism ofca lieine,enhanee the elieets ofthe oral antieoagulant, wartarin,and its derivatives and hasbeenassociated with transient elevations inserumereat inine inpatients reeeiving cyelosporine eoneomitantly. Careinogenesls, Mutagenesis, Impairment ofFertility: Eight invitro mutagenieity tests have been eondueted witheiprofloxaeinand the test resul tsare Iisted below:
ADVERSE REACTIONS
Safmonelfa,t,lierosome Test (Negative)
E. eofi DNARepair Assay (Negative)
Mouse LymphomaCell Forward Mutation Assay (Positive) Chinese Hamst erV. Cell HGPRT Test (Negative) Syrian HamsterEmbryo Cell Transformat ionAssay (Negative) Saeeharomyees eerevisiae PointMutation Assay (Negative) Saeeharomyees cerevisiae Mitotie Crossover and Gene Conversion Assay (Negative) RatHepatocyteDNARepair Assay (Positive) Thus, two 01 the eight tests were positive, but the results ofthe following thr eeinvivo test systems gave negativeresults:
Rat HepatoeyteDNARepair Assay Mieronueleus Test (Miee) Dominant Let hal Test(Miee) Longter mcarcinogenieity studies inmiee and rats have been eompleted. Alier dailyoral dosing for upto two years, there is no evidenee that ei prolloxaein had anycareinogenie ortumorigenie elieets in these speeles. Pregnaney -Pregnaney Category C: Reproductionstudies have been pertormed inrats and mieeatdoses up tosixtimes the usual daily humanoral doseand have reveal ednoevidenee ofimpaired lertility orharm tothe fetus due to eiprofloxaein. In rabbits, as wit hmost antimierobial agents, eiprolloxaein (30and 100 mgJl<g orally) produeed gastrointestinal disturbanees resulting in maternai weight loss and an inereased incidenee 01abortion. No teratogenieitywas observed ateit her dose. Alier intravenous administration,at doses up to 20mgJl<g, no maternai toxiei tywas produeed and noembryotoxieity or teratogenieity was observed. There are noadequate and weil eontrolledstudies inpregnant women. CILDXAN shouldbeused during pregnancy onlyif thepotential benelit justifies the potential risk tothe fetus. Nursing Mothers: It is notknown whether topically applied eiprolloxaeinisexereted inhuman milk; however, it is known that orally administered eiprofloxaein is exereted in the milkof laetating rats and oral eiprofloxaeinhas been reported inhumanbreast milk alier asingle 500 mg dose. Caution shouldbe exereised when CILOXAN isadministered toanursing mother. PediatrieUse: Salety and effeetiveness inpediatrie patients below the age 01 1year (solut ion)and 2years (ointment) have notbeen established. Although eiprofloxaein and other quinolones cause arthropathy inimmature Beagle dogs alier oral administration, topical oeular administration01 eiprofloxaein toimmatureanimals did noteause any arthropathy andthereisnoevidenee that the ophthalmledosage lormhasany effeet onthe weight bearing joints. ADVERSE REACTIONS: Themost Irequently reporteddrug related adverse reaetion was local burning or diseomlort. Incomeal uleerstudies wit hfrequent administration ofthe drug, white crystalline preeipitates were seen inapproximately 17% (solution) and 13% (ointment) ofpatients (SEEPRECAUTI ONS). Other reaetionsoeeurring inless than10%ofpallents ineluded lidmarginerusting,erystalslscales, foreign body sensation, hehing, eonjunetival hyperemiaand abad taste following instillation. Additional events oeeur· ring in less than 1% 01patients ineluded comeal staining, keratopathylkeratitis, allergie reaetions, Ii d edema, tearing, photophobia, comeal inliltrates, nausea and deereased vision, blurred vision, dryeve, epitheliopathy, eve pain, irritation and dermatitis. DVERDOSAGE: Atopieal overdose ofCILOXANOphthalmie Solution orOintment may be flushed fromthe evets) wit h warmtap water. ANIMAL PHARMACOLDGY: Ciprofloxaein and related drugs have been
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shown toeause arth ropathy inImmatureani mals of most speeies tested con following oral administration. However, aone-monthtopĩ 1 oe ul a~study 
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